These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7741935)

  • 1. Alzheimer's and Cognex.
    Steel JG
    N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease: a new hope.
    Hasan MK; Mooney D
    W V Med J; 1994 Oct; 90(10):418-9. PubMed ID: 7801627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B; Haramburu F; Miremont G
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tacrine in the treatment of Alzheimer's disease].
    Weinstein HC; Teunisse S; van Gool WA; van Crevel H
    Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrine for Alzheimer's disease.
    Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT; Guardado-Santervás P
    Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatments for Alzheimer's disease.
    Harvey R; Rossor M
    Practitioner; 1995 Jul; 239(1552):440-3. PubMed ID: 7659667
    [No Abstract]   [Full Text] [Related]  

  • 9. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of tacrine hydrochloride (Cognex) in private practice.
    Howell GJ
    Acta Neurol Scand Suppl; 1996; 165():123-7. PubMed ID: 8740999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
    Scheen AJ
    Rev Med Liege; 1996 May; 51(5):379-81. PubMed ID: 8992561
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective.
    Pendlebury WW; Solomon PR
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease].
    Estadieu MC; Machou C; Berthezène P; Pastor MJ; Angelini B; Bohor M; Bongrand MC; Timon-David P; Gastaut JL; Allain H; Michel BF
    Therapie; 1998; 53(1):67-76. PubMed ID: 9773102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC
    Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine in Alzheimer's disease.
    Lachs M
    N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrine for Alzheimer's disease.
    Kelly BT
    Am Fam Physician; 1995 Sep; 52(3):779. PubMed ID: 7653420
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrine in Alzheimer's disease.
    Patocka J; Fusek J
    Homeost Health Dis; 1991; 33(4):161. PubMed ID: 1818685
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alzheimer disease cannot be treated with Cognex].
    Shafazand M
    Lakartidningen; 1996 Apr; 93(15):1406. PubMed ID: 8667714
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low.
    Roberts C; Mäkelä P; Ford J; Truman C
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response.
    Levy R
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.